 | • レポートコード：20QY06-04876 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、核医学/放射性医薬品のグローバル市場について種類別（診断、治療）、用途別（腫瘍、甲状腺、心臓病）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・核医学/放射性医薬品市場の概要 ・世界の主要地域別核医学/放射性医薬品市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の核医学/放射性医薬品市場規模2015-2026：種類別（診断、治療） ・世界の核医学/放射性医薬品市場規模2015-2026：用途別（腫瘍、甲状腺、心臓病） ・核医学/放射性医薬品の北米市場規模2015-2020 ・核医学/放射性医薬品のヨーロッパ市場規模2015-2020 ・核医学/放射性医薬品の中国市場規模2015-2020 ・核医学/放射性医薬品の日本市場規模2015-2020 ・核医学/放射性医薬品の東南アジア市場規模2015-2020 ・核医学/放射性医薬品のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （China Isotope & Radiation、Dongcheng、Jaco、Ciaeriar、Advanced Molecular-imaging Solution、Shanghai Atom Kexing） ・核医学/放射性医薬品の製造コスト分析 ・販売チャネル、流通業者、顧客 ・核医学/放射性医薬品の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Nuclear Medicine/Radiopharmaceuticals Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Nuclear Medicine/Radiopharmaceuticals market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Nuclear Medicine/Radiopharmaceuticals market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Nuclear Medicine/Radiopharmaceuticals industry.
Based on our recent survey, we have several different scenarios about the Nuclear Medicine/Radiopharmaceuticals YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 5435.6 million in 2019. The market size of Nuclear Medicine/Radiopharmaceuticals will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Nuclear Medicine/Radiopharmaceuticals market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Nuclear Medicine/Radiopharmaceuticals market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Nuclear Medicine/Radiopharmaceuticals market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Nuclear Medicine/Radiopharmaceuticals market. The report also includes nautical information, where it shows Nuclear Medicine/Radiopharmaceuticals market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Nuclear Medicine/Radiopharmaceuticals market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Nuclear Medicine/Radiopharmaceuticals market.
Nuclear medicine is a medical specialty that allows modern diagnostics and treatments using radiopharmaceuticals original radiotracers. Radiopharmaceuticals are considered a special group of drugs and thus their preparation and use are regulated by a set of policies that have been adopted by individual member countries. In China, radioactive drug approval process is cumbersome, drug research and development cycle is too long and the high-end equipment of China mainly relies on imports, which restrict the development of nuclear medicine.
Geographical Analysis:
Based on region, the global Nuclear Medicine/Radiopharmaceuticals market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Nuclear Medicine/Radiopharmaceuticals market are
China Isotope & Radiation
Dongcheng
Jaco
Ciaeriar
Advanced Molecular-imaging Solution
Shanghai Atom Kexing
…
Segment by Type
Diagnostic
Therapeutic
Segment by Application
Oncology
Thyroid
Cardiology
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Nuclear Medicine/Radiopharmaceuticals market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Nuclear Medicine/Radiopharmaceuticals market.
• The market share of the global Nuclear Medicine/Radiopharmaceuticals market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Nuclear Medicine/Radiopharmaceuticals market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Nuclear Medicine/Radiopharmaceuticals market.
1 Nuclear Medicine/Radiopharmaceuticals Market Overview
1.1 Nuclear Medicine/Radiopharmaceuticals Product Scope
1.2 Nuclear Medicine/Radiopharmaceuticals Segment by Type
1.2.1 Global Nuclear Medicine/Radiopharmaceuticals Sales by Type (2020-2026)
1.2.2 Diagnostic
1.2.3 Therapeutic
1.3 Nuclear Medicine/Radiopharmaceuticals Segment by Application
1.3.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Comparison by Application (2020-2026)
1.3.2 Oncology
1.3.3 Thyroid
1.3.4 Cardiology
1.4 Nuclear Medicine/Radiopharmaceuticals Market Estimates and Forecasts (2015-2026)
1.4.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2026)
1.4.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2015-2026)
1.4.3 Global Nuclear Medicine/Radiopharmaceuticals Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Nuclear Medicine/Radiopharmaceuticals Industry Impact
1.5.1 How the Covid-19 is Affecting the Nuclear Medicine/Radiopharmaceuticals Industry
1.5.1.1 Nuclear Medicine/Radiopharmaceuticals Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Nuclear Medicine/Radiopharmaceuticals Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Nuclear Medicine/Radiopharmaceuticals Players to Combat Covid-19 Impact
2 Nuclear Medicine/Radiopharmaceuticals Estimate and Forecast by Region
2.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Nuclear Medicine/Radiopharmaceuticals Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Region (2015-2020)
2.2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region (2015-2020)
2.3 Global Nuclear Medicine/Radiopharmaceuticals Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Nuclear Medicine/Radiopharmaceuticals Estimates and Projections (2015-2026)
2.4.2 Europe Nuclear Medicine/Radiopharmaceuticals Estimates and Projections (2015-2026)
2.4.3 China Nuclear Medicine/Radiopharmaceuticals Estimates and Projections (2015-2026)
2.4.4 Japan Nuclear Medicine/Radiopharmaceuticals Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Estimates and Projections (2015-2026)
2.4.6 India Nuclear Medicine/Radiopharmaceuticals Estimates and Projections (2015-2026)
3 Global Nuclear Medicine/Radiopharmaceuticals Competition Landscape by Players
3.1 Global Top Nuclear Medicine/Radiopharmaceuticals Players by Sales (2015-2020)
3.2 Global Top Nuclear Medicine/Radiopharmaceuticals Players by Revenue (2015-2020)
3.3 Global Nuclear Medicine/Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine/Radiopharmaceuticals as of 2019)
3.4 Global Nuclear Medicine/Radiopharmaceuticals Average Price by Company (2015-2020)
3.5 Manufacturers Nuclear Medicine/Radiopharmaceuticals Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Nuclear Medicine/Radiopharmaceuticals Players (Opinion Leaders)
4 Global Nuclear Medicine/Radiopharmaceuticals Market Size by Type
4.1 Global Nuclear Medicine/Radiopharmaceuticals Historic Market Review by Type (2015-2020)
4.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
4.1.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Type (2015-2020)
4.1.3 Global Nuclear Medicine/Radiopharmaceuticals Price by Type (2014-2020)
4.2 Global Nuclear Medicine/Radiopharmaceuticals Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Type (2021-2026)
4.2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Type (2021-2026)
4.2.3 Global Nuclear Medicine/Radiopharmaceuticals Price Forecast by Type (2021-2026)
5 Global Nuclear Medicine/Radiopharmaceuticals Market Size by Application
5.1 Global Nuclear Medicine/Radiopharmaceuticals Historic Market Review by Application (2015-2020)
5.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
5.1.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Application (2015-2020)
5.1.3 Global Nuclear Medicine/Radiopharmaceuticals Price by Application (2015-2020)
5.2 Global Nuclear Medicine/Radiopharmaceuticals Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Application (2021-2026)
5.2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Application (2021-2026)
5.2.3 Global Nuclear Medicine/Radiopharmaceuticals Price Forecast by Application (2021-2026)
3 North America Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures
3.2 North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (2015-2020)
3.3 North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
3.4 North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
4 Europe Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures
4.2 Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (2015-2020)
4.3 Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
4.4 Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
5 China Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures
5.2 China Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (2015-2020)
5.3 China Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
5.4 China Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
6 Japan Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures
6.2 Japan Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (2015-2020)
6.3 Japan Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
6.4 Japan Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
7 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures
7.2 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
8 India Nuclear Medicine/Radiopharmaceuticals Market Facts & Figures
8.2 India Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (2015-2020)
8.3 India Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
8.4 India Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Nuclear Medicine/Radiopharmaceuticals Business
12.1 China Isotope & Radiation
12.1.1 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Corporation Information
12.1.2 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Business Overview and Total Revenue
12.1.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.1.4 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Products Offered
12.1.5 China Isotope & Radiation Recent Development
12.2 Dongcheng
12.2.1 Dongcheng Nuclear Medicine/Radiopharmaceuticals Corporation Information
12.2.2 Dongcheng Nuclear Medicine/Radiopharmaceuticals Business Overview and Total Revenue
12.2.3 Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Dongcheng Nuclear Medicine/Radiopharmaceuticals Products Offered
12.2.5 Dongcheng Recent Development
12.3 Jaco
12.3.1 Jaco Nuclear Medicine/Radiopharmaceuticals Corporation Information
12.3.2 Jaco Nuclear Medicine/Radiopharmaceuticals Business Overview and Total Revenue
12.3.3 Jaco Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Jaco Nuclear Medicine/Radiopharmaceuticals Products Offered
12.3.5 Jaco Recent Development
12.4 Ciaeriar
12.4.1 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Corporation Information
12.4.2 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Business Overview and Total Revenue
12.4.3 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Products Offered
12.4.5 Ciaeriar Recent Development
12.5 Advanced Molecular-imaging Solution
12.5.1 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Corporation Information
12.5.2 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Business Overview and Total Revenue
12.5.3 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Products Offered
12.5.5 Advanced Molecular-imaging Solution Recent Development
12.6 Shanghai Atom Kexing
12.6.1 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Corporation Information
12.6.2 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Business Overview and Total Revenue
12.6.3 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Products Offered
12.6.5 Shanghai Atom Kexing Recent Development
…
13 Nuclear Medicine/Radiopharmaceuticals Manufacturing Cost Analysis
13.1 Nuclear Medicine/Radiopharmaceuticals Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceuticals
13.4 Nuclear Medicine/Radiopharmaceuticals Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Nuclear Medicine/Radiopharmaceuticals Distributors List
14.3 Nuclear Medicine/Radiopharmaceuticals Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Nuclear Medicine/Radiopharmaceuticals Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Nuclear Medicine/Radiopharmaceuticals Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Nuclear Medicine/Radiopharmaceuticals Players to Combat Covid-19 Impact
Table 8. Global Market Nuclear Medicine/Radiopharmaceuticals Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Region (2015-2020)
Table 10. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Region (2015-2020)
Table 11. Global Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Region (2015-2020)
Table 13. Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Nuclear Medicine/Radiopharmaceuticals Revenue Share Forecast by Region (2021-2026)
Table 17. Global Nuclear Medicine/Radiopharmaceuticals (K Units) of Key Companies (2015-2020)
Table 18. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Company (2015-2020)
Table 19. Global Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Company (2015-2020)
Table 21. Global Nuclear Medicine/Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine/Radiopharmaceuticals as of 2019)
Table 22. Global Nuclear Medicine/Radiopharmaceuticals Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Nuclear Medicine/Radiopharmaceuticals Manufacturing Sites and Area Served
Table 24. Manufacturers Nuclear Medicine/Radiopharmaceuticals Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Nuclear Medicine/Radiopharmaceuticals Players
Table 27. Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Type (2015-2020)
Table 28. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Type (2015-2020)
Table 29. Global Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Nuclear Medicine/Radiopharmaceuticals Price (K Units) by Type (2015-2020)
Table 31. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Type (2021-2026)
Table 32. Global Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Type (2021-2026)
Table 34. Global Nuclear Medicine/Radiopharmaceuticals Price (K Units) by Type (2021-2026)
Table 35. Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Application (2015-2020)
Table 36. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Application (2015-2020)
Table 37. Global Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Nuclear Medicine/Radiopharmaceuticals Price (K Units) by Application (2015-2020)
Table 39. Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Application (2021-2026)
Table 40. Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Application (2021-2026)
Table 41. Global Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Application (2021-2026)
Table 43. Global Nuclear Medicine/Radiopharmaceuticals Price (K Units) by Application (2021-2026)
Table 44. United States Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Company (2015-2020)
Table 45. United States Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (2015-2020)
Table 46. United States Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Type (2015-2020)
Table 47. United States Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 48. United States Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Application (2015-2020)
Table 49. United States Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 50. Europe Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Company (2015-2020)
Table 51. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (2015-2020)
Table 52. Europe Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Type (2015-2020)
Table 53. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 54. Europe Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Application (2015-2020)
Table 55. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 56. China Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Company (2015-2020)
Table 57. China Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (2015-2020)
Table 58. China Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Type (2015-2020)
Table 59. China Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 60. China Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Application (2015-2020)
Table 61. China Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 62. Japan Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Company (2015-2020)
Table 63. Japan Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (2015-2020)
Table 64. Japan Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Type (2015-2020)
Table 65. Japan Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 66. Japan Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Application (2015-2020)
Table 67. Japan Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 74. India Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Company (2015-2020)
Table 75. India Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (2015-2020)
Table 76. India Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Type (2015-2020)
Table 77. India Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 78. India Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Application (2015-2020)
Table 79. India Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 80. China Isotope & Radiation Corporation Information
Table 81. China Isotope & Radiation Description and Business Overview
Table 82. China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Product
Table 84. China Isotope & Radiation Recent Development
Table 85. Dongcheng Corporation Information
Table 86. Dongcheng Description and Business Overview
Table 87. Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Dongcheng Nuclear Medicine/Radiopharmaceuticals Product
Table 89. Dongcheng Recent Development
Table 90. Jaco Corporation Information
Table 91. Jaco Description and Business Overview
Table 92. Jaco Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Jaco Nuclear Medicine/Radiopharmaceuticals Product
Table 94. Jaco Recent Development
Table 95. Ciaeriar Corporation Information
Table 96. Ciaeriar Description and Business Overview
Table 97. Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Ciaeriar Nuclear Medicine/Radiopharmaceuticals Product
Table 99. Ciaeriar Recent Development
Table 100. Advanced Molecular-imaging Solution Corporation Information
Table 101. Advanced Molecular-imaging Solution Description and Business Overview
Table 102. Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Product
Table 104. Advanced Molecular-imaging Solution Recent Development
Table . Shanghai Atom Kexing Corporation Information
Table . Shanghai Atom Kexing Description and Business Overview
Table . Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Product
Table . Shanghai Atom Kexing Recent Development
Table 110. Production Base and Market Concentration Rate of Raw Material
Table 111. Key Suppliers of Raw Materials
Table 112. Nuclear Medicine/Radiopharmaceuticals Distributors List
Table 113. Nuclear Medicine/Radiopharmaceuticals Customers List
Table 114. Market Key Trends
Table 115. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 116. Key Challenges
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Nuclear Medicine/Radiopharmaceuticals Product Picture
Figure 2. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Nuclear Medicine/Radiopharmaceuticals Market Share by Application in 2020 & 2026
Figure 6. Oncology Examples
Figure 7. Thyroid Examples
Figure 8. Cardiology Examples
Figure 9. Global Nuclear Medicine/Radiopharmaceuticals Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Nuclear Medicine/Radiopharmaceuticals Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Nuclear Medicine/Radiopharmaceuticals Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Nuclear Medicine/Radiopharmaceuticals Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Nuclear Medicine/Radiopharmaceuticals Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Nuclear Medicine/Radiopharmaceuticals Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Nuclear Medicine/Radiopharmaceuticals Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Nuclear Medicine/Radiopharmaceuticals Players Market Share by Revenue in Nuclear Medicine/Radiopharmaceuticals 2015 & 2019
Figure 27. Nuclear Medicine/Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Type (2015-2020)
Figure 29. Global Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Application (2015-2020)
Figure 31. Global Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type in 2019
Figure 33. United States Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type in 2019
Figure 34. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company in 2019
Figure 35. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type in 2019
Figure 36. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application in 2019
Figure 37. China Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company in 2019
Figure 38. China Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type in 2019
Figure 39. China Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application in 2019
Figure 40. Japan Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company in 2019
Figure 41. Japan Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type in 2019
Figure 42. Japan Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application in 2019
Figure 43. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company in 2019
Figure 44. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type in 2019
Figure 45. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application in 2019
Figure 46. India Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company in 2019
Figure 47. India Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type in 2019
Figure 48. India Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application in 2019
Figure 49. China Isotope & Radiation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Dongcheng Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Jaco Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Ciaeriar Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Advanced Molecular-imaging Solution Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Shanghai Atom Kexing Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Key Raw Materials Price Trend
Figure 56. Manufacturing Cost Structure of Nuclear Medicine/Radiopharmaceuticals
Figure 57. Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceuticals
Figure 58. Nuclear Medicine/Radiopharmaceuticals Industrial Chain Analysis
Figure 59. Channels of Distribution
Figure 60. Distributors Profiles
Figure 61. Porter's Five Forces Analysis
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
核医学/放射性医薬品の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Nuclear Medicine/Radiopharmaceutic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Nuclear Me…- 診断用放射性医薬品＆造影剤の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Diagnostic Radiopharmaceuticals & Contrast Media market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.9% in the forecast period of 2020 to 2025 and will expected to reach USD 9594.6 million by 2025, from USD 8567.7 million …
- 核ロボットの世界市場レポート2020 Market Analysis and Insights: Global Nuclear Robotics Market The global Nuclear Robotics market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Nuclear Robotics Scope and Market Size The global Nuclear Robotics …
- 原子力電池の世界市場レポート2020 Market Analysis and Insights: Global Nuclear Battery Market The global Nuclear Battery market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Nuclear Battery Scope and Market Size The global Nuclear Battery mark…
- 600MHz核磁気共鳴分光計の世界市場 2020年：メーカー別、地域別、種類・用途別 Summary Market Overview The global 600 MHz Nuclear Magnetic Resonance Spectrometer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.8% in the forecast period of 2020 to 2025 and will expected to reach USD 137.1 million by 2025, from USD 118 milli…